Dr. Joaquim Trias, Advisor to the Board of Directors of SOM Biotech ran the third annual Bay Area Fox Trot 5K Run/Walk for Parkinson’s Research, last October 13th Sunday in San Mateo.
The run was organized by The Michel J. Fox Foundation, a prestigious organization launched in year 2000 by the iconic actor Michael J. Fox after publicly disclosing his diagnosis, at age 29, with Parkinson´s disease.
The Parkinson’s disease is one of the most promising programs for SOM Biotech, where we have identified re-innovated alfa-synuclein aggregation inhibitors. By blocking alfa-synuclein aggregation inside neurons, these compounds are expected to prevent disease progression and have the potential to become the first disease modifying therapy available for Parkinson disease patients.
You can find more information about the event here.